Medpace Newsroom

Baird Adjusts Medpace Holdings' Price Target to $469 From $456, Keeps Outperform Rating

MT NewswiresJul 8 12:32 ET

Medpace Hldgs Analyst Ratings

BenzingaJul 8 12:04 ET

Medpace Hldgs Analyst Ratings

BenzingaMay 29 07:24 ET

Medpace Holdings (MEDP) Receives a New Rating From TD Cowen

TipRanksMay 29 05:50 ET

Medpace Hldgs Analyst Ratings

BenzingaMay 28 05:22 ET

Medpace Holdings (MEDP): A Strong Buy on Robust Organic Growth and Financial Stability

TipRanksMay 28 04:39 ET

Medpace Hldgs Analyst Ratings

BenzingaApr 24 13:44 ET

Medpace Hldgs Analyst Ratings

BenzingaApr 23 11:08 ET

Medpace Hldgs Analyst Ratings

BenzingaMar 18 08:17 ET

Medpace Hldgs Analyst Ratings

BenzingaMar 8 12:08 ET

Medpace Hldgs Analyst Ratings

BenzingaFeb 14 14:03 ET

Medpace Hldgs Analyst Ratings

BenzingaJan 17 14:30 ET

UBS Adjusts Medpace Price Target to $282 From $270, Maintains Neutral Rating

MT NewswiresOct 25, 2023 11:31 ET

Medpace Holdings (NASDAQ:MEDP) Explodes Upward After Earnings, Analyst Weigh-In

TipRanksOct 24, 2023 12:02 ET

Baird Upgrades Medpace Hldgs to Outperform, Raises Price Target to $289

BenzingaOct 24, 2023 06:17 ET

Medpace Hldgs Analyst Ratings

BenzingaOct 24, 2023 06:15 ET

Analysts Conflicted on These Healthcare Names: Medpace Holdings (MEDP) and Silk Road Medical (SILK)

TipRanksOct 24, 2023 04:40 ET

UBS Adjusts Medpace Price Target to $270 From $215, Maintains Neutral Rating

MT NewswiresJul 26, 2023 11:38 ET

Guggenheim Raises Medpace Holdings' Price Target to $273 From $252, Keeps Buy Rating

MT NewswiresJul 25, 2023 10:41 ET

Guggenheim Maintains Buy on Medpace Hldgs, Raises Price Target to $273

BenzingaJul 25, 2023 08:45 ET